drugset / Trial / NCT00630929

Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)

NCT00630929 ↗

Phase 4 Completed 388 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the efficacy and safety of celecoxib versus ibuprofen in subjects with osteoarthritis (OA) of the knee.

Timeline

Start
2003-01
Primary completion
—
Completion
2004-02

Outcome

Met primary endpoint

paper As the lower bound was greater than -10, celecoxib was non-inferior to ibuprofen. PMID 28222627 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral
Comparator Ibuprofen Small molecule 800 mg Oral

Indications